Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Melanoma vaccines. Current status and future prospects.

× No keyword cloud information.

58 in total

1. At age 2, gene therapy enters a growth phase.

Authors: L Thompson
Journal: Science Date: 1992-10-30 Impact factor: 47.728

2. RAC unanimously approves cancer vaccine trial.

Authors: S Jenks
Journal: J Natl Cancer Inst Date: 1992-07-01 Impact factor: 13.506

Review 3. Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?

Authors: G Parmiani; A Anichini; G Fossati
Journal: J Natl Cancer Inst Date: 1990-03-07 Impact factor: 13.506

4. Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines.

Authors: P O Livingston
Journal: Ann N Y Acad Sci Date: 1993-08-12 Impact factor: 5.691

Review 5. Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

Authors: P K Srivastava
Journal: Adv Cancer Res Date: 1993 Impact factor: 6.242

6. Western blot analysis of serological responses following immunization with vaccinia viral lysates of melanoma cells.

Authors: P Hersey; H Werkman; A E Edwards
Journal: Int J Cancer Date: 1990-10-15 Impact factor: 7.396

7. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma.

Authors: F J Tefany; R S Barnetson; G M Halliday; S W McCarthy; W H McCarthy
Journal: J Invest Dermatol Date: 1991-08 Impact factor: 8.551

8. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules.

Authors: S Baskar; S Ostrand-Rosenberg; N Nabavi; L M Nadler; G J Freeman; L H Glimcher
Journal: Proc Natl Acad Sci U S A Date: 1993-06-15 Impact factor: 11.205

Review 9. Gene therapy for cancer.

Authors: A A Gutierrez; N R Lemoine; K Sikora
Journal: Lancet Date: 1992-03-21 Impact factor: 79.321

10. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors: C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal: J Exp Med Date: 1992-11-01 Impact factor: 14.307

1 in total

Review 1. Immunotherapy for melanoma: current status and perspectives.

Authors: Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan; Francesco M Marincola; Anna Di Nardo; Filamer D Kabigting; Constantin A Dasanu
Journal: J Immunother Date: 2010 Jul-Aug Impact factor: 4.456

1 in total